Category
Healthcare
Pharmaceutical companies, biotechnology, healthcare services, and medical device manufacturers. Drug approvals, clinical trials, and sector dynamics.
Healthcare
JNJ Q2 2026 update — filings and holdings
Healthcare
ABBV Q2 2026: filings, holdings, and macro context
Healthcare
AMGN Q1 2026: filings, holdings, and macro context
Healthcare
PFE Q2 2026 update — filings and holdings
Healthcare
MRK Q2 2026: filings, holdings, and macro context
Healthcare
LLY Q2 2026 update — filings and holdings
Healthcare
UNH Q2 2026 update — filings and holdings
Healthcare
ABBV Q2 2026: filings, holdings, and macro context
Healthcare
AMGN Q1 2026: filings, holdings, and macro context
Healthcare
PFE Q2 2026 update — filings and holdings
Healthcare
MRK Q2 2026 update — filings and holdings
Healthcare
LLY Q2 2026 update — filings and holdings
Healthcare
UNH Q2 2026: filings, holdings, and macro context
Healthcare
GILD Q2 2026: filings, holdings, and macro context
Healthcare
ABBV Q2 2026 update — filings and holdings
Healthcare
AMGN Q1 2026: filings, holdings, and macro context
Healthcare
PFE Q2 2026 update — filings and holdings
Healthcare
MRK Q1 2026: filings, holdings, and macro context
Healthcare
LLY Q2 2026 update — filings and holdings
Healthcare
UNH Q2 2026 update — filings and holdings
Healthcare
ABBV Q2 2026: filings, holdings, and macro context
Healthcare
AMGN Q1 2026: filings, holdings, and macro context
Healthcare
PFE Q2 2026 update — filings and holdings
Healthcare